Grifols SA (GRFS)
6.38
-0.16
(-2.45%)
USD |
NASDAQ |
Apr 19, 11:18
Grifols EPS Diluted (TTM): 0.3111 for Dec. 31, 2023
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.3111 |
| September 30, 2023 | 0.2884 |
| June 30, 2023 | 0.3346 |
| December 31, 2022 | 0.4791 |
| September 30, 2022 | 0.678 |
| June 30, 2022 | 0.8385 |
| June 30, 2021 | 1.153 |
| March 31, 2021 | 0.9668 |
| December 31, 2020 | 1.038 |
| September 30, 2020 | 1.133 |
| June 30, 2020 | 0.8987 |
| March 31, 2020 | 1.124 |
| December 31, 2019 | 1.017 |
| September 30, 2019 | 0.9012 |
| June 30, 2019 | 0.9351 |
| March 31, 2019 | 0.9647 |
| December 31, 2018 | 1.030 |
| September 30, 2018 | 1.222 |
| June 30, 2018 | 1.225 |
| March 31, 2018 | 1.146 |
| December 31, 2017 | 1.097 |
| September 30, 2017 | 0.9189 |
| June 30, 2017 | 0.8947 |
| March 31, 2017 | 0.8896 |
| Date | Value |
|---|---|
| December 31, 2016 | 0.8791 |
| September 30, 2016 | 0.8668 |
| June 30, 2016 | 0.8547 |
| March 31, 2016 | 0.8387 |
| December 31, 2015 | 0.8545 |
| September 30, 2015 | 0.8901 |
| June 30, 2015 | 0.8865 |
| March 31, 2015 | 0.8823 |
| December 31, 2014 | 0.9077 |
| September 30, 2014 | 0.8207 |
| June 30, 2014 | 0.7677 |
| March 31, 2014 | 0.7383 |
| December 31, 2013 | 0.6768 |
| September 30, 2013 | 0.6305 |
| June 30, 2013 | 0.5836 |
| March 31, 2013 | 0.5292 |
| December 31, 2012 | 0.4821 |
| September 30, 2012 | 0.3851 |
| June 30, 2012 | 0.3201 |
| March 31, 2012 | 0.157 |
| December 31, 2011 | 0.1301 |
| September 30, 2011 | 0.1758 |
| June 30, 2011 | 0.2148 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (TTM) Range, Past 5 Years
0.2884
Minimum
Sep 2023
1.153
Maximum
Jun 2021
0.8065
Average
0.9012
Median
Sep 2019
EPS Diluted (TTM) Benchmarks
| DBV Technologies SA | -0.38 |
| Adaptimmune Therapeutics PLC | -0.4738 |
| Biodexa Pharmaceuticals Plc | -837.96 |
| NuCana PLC | -16.46 |
| Autolus Therapeutics PLC | -1.20 |